Please provide your email address to receive an email when new articles are posted on . Apremilast led to better clinical outcomes in early oligoarticular PsA vs. placebo at 16 weeks. Safety was ...

Celgene has good news and bad news with its latest apremilast results. Bad news The phase 3 results were a considerable letdown when compared to phase 2 results. Back in December 2009, Celgene ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At week 16, 55.9% of the risankizumab group and 5.1% of ...

More patients with oligoarticular psoriatic arthritis (PsA) saw symptoms largely disappear when apremilast (Otezla) was started early in the disease course compared with placebo, a randomized trial ...

SAN DIEGO, CA—Patients with active psoriatic arthritis treated with apremilast reported clinically meaningful improvements in signs and symptoms and physical function over 52 weeks compared with ...

Novel PDE-4 inhibitor continues to be well tolerated with an acceptable long-term safety profile Madrid, Spain, 12 June 2013: New data presented today at EULAR 2013, the Annual Congress of the ...

BOUDRY, Switzerland--(BUSINESS WIRE)--Mar. 2, 2013-- Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company's first phase ...

SAN FRANCISCO, CA—Longer-term efficacy and safety data from the Phase 3 PALACE 1 study have confirmed that apremilast at 20mg and 30mg twice-daily doses continues to demonstrate “sustained and ...

Researchers conducted a multicenter observational study across three major US academic medical centers with registries of patients with rheumatic immune-related adverse events to assess the ...

As per IQVIATM sales data covering the 12-month period up to August 2023, the market for Otezla® tablets in these dosage forms achieved annual sales of around $3.7 billion. Mumbai: Glenmark ...

Improvements in disease severity and quality of life measures among adults with psoriasis who are receiving apremilast was independent of genital psoriasis involvement. Apremilast improves disease ...

Review the side-effects of Apremilast as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...